Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Arcadia Biosciences, Inc. (RKDA) had Earnings per Share (EPS) (Basic) of $-0.98 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.90M |
|
$-1.34M |
|
$0.71M |
|
$0.19M |
|
$2.28M |
|
$-1.38M |
|
$0.05M |
|
$-1.33M |
|
$-1.33M |
|
$-1.34M |
|
$-1.34M |
|
$-1.34M |
|
$-1.34M |
|
$-1.38M |
|
$-1.38M |
|
1.37M |
|
1.37M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.98 |
$-0.97 |
|
| Balance Sheet Financials | |
$6.36M |
|
$0.01M |
|
$0.19M |
|
$6.55M |
|
$2.06M |
|
-- |
|
$0.35M |
|
$2.41M |
|
$4.14M |
|
$4.10M |
|
$4.14M |
|
1.37M |
|
| Cash Flow Statement Financials | |
$-4.74M |
|
$0.75M |
|
$0.01M |
|
$4.24M |
|
$0.26M |
|
$-3.98M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
21.42% |
|
-152.83% |
|
-152.83% |
|
-- |
|
-147.39% |
|
-148.28% |
|
$-4.74M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.58 |
|
2.12 |
|
42.45 |
|
-32.27% |
|
-32.58% |
|
-20.41% |
|
-32.27% |
|
$3.02 |
|
$-3.46 |
|
$-3.46 |
|